Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 43

Results For "MD"

1040 News Found

Doceree raises US$ 35 million in Series B Funding
News | September 29, 2023

Doceree raises US$ 35 million in Series B Funding

Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe


Mandaviya reviews preparedness to prevent rising dengue cases
Healthcare | September 28, 2023

Mandaviya reviews preparedness to prevent rising dengue cases

Minister was briefed on the nationwide dengue situation


Alkem rolls out patient awareness drive under its breathe initiative
News | September 28, 2023

Alkem rolls out patient awareness drive under its breathe initiative

Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India


Federal Bank Hormis Memorial Foundation, Tata Trusts and News18 join hands to launch ‘Sanjeevani’
News | September 27, 2023

Federal Bank Hormis Memorial Foundation, Tata Trusts and News18 join hands to launch ‘Sanjeevani’

‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic


Need for strengthening primary and secondary healthcare network at the urban level: Health Secretary
Policy | September 23, 2023

Need for strengthening primary and secondary healthcare network at the urban level: Health Secretary

The state of the healthcare services will improve substantially with the involvement and participation of ULBs


Torque Pharmaceuticals launches campaign to celebrate World Pharmacist Day
News | September 22, 2023

Torque Pharmaceuticals launches campaign to celebrate World Pharmacist Day

The campaign for the digital film is being amplified across various digital media platforms such as YouTube, Facebook, Instagram, Twitter, and LinkedIn


Biocon Biologics receives European Commission approval for biosimilar of Aflibercept ‘Yesafili’
Drug Approval | September 21, 2023

Biocon Biologics receives European Commission approval for biosimilar of Aflibercept ‘Yesafili’

The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway


Parexel appoints Gwyn Bebb to lead oncology clinical development
People | September 21, 2023

Parexel appoints Gwyn Bebb to lead oncology clinical development

Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need


Biocon names Peter Bains as Group CEO
People | September 19, 2023

Biocon names Peter Bains as Group CEO

Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect


Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia
Drug Approval | September 19, 2023

Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia

Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy